tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Thibault Boutherin, 13 are a HOLD (46.43%), 9 are a BUY (32.14%), 6 are a SELL (21.43%).
Analyst Thibault Boutherin, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 47.92% that have a potential upside of 29.63% achieved within 425 days.
Thibault Boutherin’s has documented 53 price targets and ratings displayed on 8 stocks. The coverage is on Consumer Cyclical, Healthcare sectors.
Most recent stock forecast was given on NVO, Novo Nordisk A/S at 11-Sep-2026.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 9/11/2026. The price target of $40 was fulfilled within 10 days with a profit of $3.07 (7.13%) receiving and performance score of 7.13.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 22-Feb-2023
$12.78
$-2.57 (-16.74%)
3 years 7 months 11 days ago
(22-Feb-2023)
2/2 (100%)
$3.3 (34.81%)
454
Buy
$13.23
$3.72 (39.12%)
$13.16
3 years 10 months 22 days ago
(11-Nov-2022)
0/2 (0%)
$3.95 (42.56%)
Hold Since 06-Oct-2020
$10.08
$-5.27 (-34.33%)
$11.77
4 years 24 days ago
(09-Sep-2022)
2/2 (100%)
$0.8 (8.62%)
202
Buy Since 19-Apr-2021
$12.24
$-3.11 (-20.26%)
$21.33
4 years 24 days ago
(09-Sep-2022)
1/2 (50%)
$2.96 (31.90%)
1021
Which stock is Thibault Boutherin most bullish on?
What Year was the first public recommendation made by Thibault Boutherin?
